You can access any of the podium or poster presentations’ abstracts by searching for it below. For the 2026 FIP world congress in Montreal, presentations and summaries from invited speakers are available below, while abstracts are published in the Pharmacy Education Journal (PEJ) here.
Export this Abstract | Print this Abstract |
Add to my preferred Abstracts list |
My preferred Abstracts list (57) |
Back to Search
Relationship between genotype and/or phage ORF type of ESBL-producing Escherichia coli and fluoroquinolones resistance
- At: PSWC2020 (2020)
- Type: Poster
- By: NISHIMURA, Nobuhiro (School of Pharmacy at Fukuoka, International University of Health and Welfare, Pharmaceutical Sciences, Japan)
- Co-author(s): Nobuhiro Nishimura: School of Pharmaceutical Sciences, International University of Health and Welfare, Okawa, Japan;Department of Pharmacy, Takagi Hospital, Okawa, Japan
Kyohei Maniwa: Clinical Laboratory Division, Shimane University Hospital, Izumo, Japan
Noriyuki Ishihara: Department of Pharmacy, Shimane University Hospital, Izumo, Japan
Hidehiko Moriyama: Clinical Laboratory Division, Shimane University Hospital, Izumo, Japan
Yutaka Tatano: School of Pharmaceutical Sciences, International University of Health and Welfare, Otawara, Japan
Kohji Naora: Department of Pharmacy, Shimane University Hospital, Izumo, Japan
Chiakii Sano: Department of Community Medicine Management, Shimane University School of Medicine, Izumo, Japan - Abstract:
Background
Extended spectrum β-lactamase (ESBL)-producing bacteria are the very important multi drug resistant bacteria and have been rapidly increasing worldwide in recent years.Purpose
The purpose of this study was to investigate the genotype and POT type of ESBL-producing E. coli and clarify the relationship with drug resistance.Methods
Sample: .. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 23 September 2026